We are thrilled to announce that our Phase 1 Single-Ascending Dose Safety study and Phase IIa Influenza Challenge study have received full approval to proceed. More information will be available shortly via press release. Dosing will commence on November 19th!
Research Bridge Partners
风险投资与私募股权管理人
Dallas，Texas 676 位关注者
World Class Returns with Midcontinent Roots
关于我们
Research Bridge Partners makes formative investments in biomedical startup companies based on the breakthroughs of preeminent innovators at mid-continent research universities—creating high quality investment opportunities that are sourced from geographies with thinner commercialization resources.
- 网站
-
https://www.researchbridgepartners.org
Research Bridge Partners的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- Dallas，Texas
- 类型
- 非营利机构
- 创立
- 2016
地点
-
主要
获取路线
3000 Pegasus Park Dr
US，Texas，Dallas，75247
Research Bridge Partners员工
-
Matt Tremblay, Ph.D.
CEO Blackbird Laboratories
-
Sunil Singhal
William Maul Measey Professor and Chief of Thoracic Surgery at University of Pennsylvania Perelman School of Medicine
-
Maggie Colonnetta
Senior Associate at Research Bridge Partners | Molecular Biology PhD
-
Lauren Cozzens
Cancer Biology PhD Candidate | NIH NRSA T32 Pre-Doctoral Trainee | Univeristy of Colorado Anschutz Medical Campus
动态
-
If you enjoy podcasts and want to learn a bit more about Research Bridge Partners, give this a listen!
This week's Research Renaissance podcast episode focuses on Dr. Lydia McClure, CEO of Research Bridge Partners, and why her firm is dedicated to fostering biomedical and life sciences innovation specifically in the central United States. Lydia discusses the early-stage research investment challenges and the nuances of bridging the language gap between scientists and venture capitalists. #Research #Investment #Innovation Listen, Like, Download and Share at Apple Podcast, Spotify, Amazon Music, and iHeart Radio.
-